Abstract
Background:
Some people with disabilities are likely at increased risk of health impacts from coronavirus disease 2019 (COVID-19).
Objective:
To describe parent-reported COVID-19 vaccination status of adolescents (aged 13–17 years) and parental intent to get their child vaccinated, among adolescents with versus without disability.
Methods:
National Immunization Survey–Child COVID Module data from interviews conducted July 22, 2021–February 26, 2022, were analyzed to assess disability status and type and COVID-19 vaccination status for adolescents (n = 12,445). Prevalence estimates with 95% confidence intervals were calculated; T-tests were conducted.
Results:
A lower percentage of adolescents with disability received ≥1 dose of COVID-19 vaccine compared to adolescents without disability (52.5% vs. 58.6%), [those with cognition (50.8%) or not performing errands independently (49.5%) disabilities were significantly lower]; and a higher percentage of parents reported intent to definitely vaccinate (9.9% vs. 6.5%) and definitely not vaccinate (14.9% vs.11.8%) their adolescent. Among the unvaccinated adolescents, parents of those with disability were more likely to report difficulty getting their child vaccinated (19.1% vs. 12.9%), inconvenient vaccination-site operating hours (7.6% vs. 3.9%), difficulty knowing where to get their child vaccinated (7.2% vs. 2.7%), and difficulty getting to vaccination sites (6.0% vs. 3.0%), than parents of those without disability.
Conclusions:
Adolescents with disability had lower vaccination coverage compared to adolescents without disability. Parents of adolescents with disability reported higher intent to get their adolescents vaccinated, but among unvaccinated adolescents with disability, parents reported greater difficulty in accessing COVID-19 vaccines. Findings highlight the need for prioritized outreach to increase COVID-19 vaccination for this population.
Keywords: Disability, Coronavirus, Health disparities, Adolescents
In the United States, 17% of children and adolescents aged 3–17 years have a reported developmental disability1 and approximately 26% of adults have a disability defined based on having at least one of six functional disability types (e.g., serious difficulty in hearing, vision, mobility, cognition, self-care, and/or independent living).2 Adults with disability are three times as likely to have heart disease, stroke, diabetes, or cancer than adults without disability,3 conditions which can place them at increased risk for severe illness from COVID-19.4 Additionally, some people with disability are likely at increased risk for greater health impact from COVID-19 not only in terms of increased infection, hospitalization, or death due to underlying medical conditions, but also due to social determinants of health, such as living in residential group homes, which poses a higher risk of severe COVID-19 outcomes for people with intellectual and developmental disabilities compared to the general population in New York State.5,6 While rates of COVID-19 infection, hospitalization, and death are lower for children than adults, children with Intellectual and Developmental Disabilities (I/DD) were found to have higher fatality rates compared to children without I/DD (ages ≤ 17 - IDD 1.6%, without IDD <0.01%).7 Adults with disability are more likely to live in group or other congregate settings where transmission rates are higher, and people with disabilities across all ages face more barriers to engaging in COVID prevention measures such as social distancing and mask wearing,8 making COVID-19 vaccination an even more important protection measure. People with disability across the lifespan face barriers in accessing timely and quality healthcare and are disproportionately impacted by delayed or reduced educational or other therapeutic services.9,10 Furthermore, O’Neill et al.11 revealed that people with disability have lower rates of vaccination, in general, compared to people without disabilities, as well as the need for further study of the role of systemic inequities as barriers to vaccination.
The scarcity of public health data systems that measure disability status as a demographic variable makes it challenging to properly assess COVID-19-related health disparities and vaccination uptake among people with a disability.12 To help address this gap in data availability, CDC added a single pilot question to assess disability status to the National Immunization Survey–Adult COVID Module. Analyses of this question showed inequities for adults with disability compared to adults without disability in COVID-19 vaccination status and perceived barriers to vaccination, despite adults with disability being more likely to report intent to get vaccinated.13 However, vaccination status among adolescents and parental intent to get their adolescent vaccinated has not previously been described by disability status or type. CDC recommends that people aged 6 months and older receive the COVID-19 vaccine primary series, along with a booster vaccination for people over 5 years.14 CDC encourages special considerations be given for groups with disproportionate COVID-19 morbidity and mortality, including people with disability, to increase availability and accessibility of vaccines.15 The objective of this study is to describe parent-reported COVID-19 vaccination status of adolescents aged 13–17 years and parental intent to get their adolescent vaccinated, as well as behavioral and social drivers of acceptance of COVID-19 vaccination, among those with disability compared to those without disability using data from the National Immunization Survey-Child COVID Module (NIS-CCM). This information might help to provide guidance for public health practice on improving vaccination coverage among people with disability.
Methods
The National Immunization Survey-Child COVID Module (NIS-CCM) is a random-digit-dial cellular telephone survey of households with children and adolescents up to 17 years of age eligible for the COVID-19 vaccine. The NIS-CCM began on July 22, 2021, including adolescents aged 13–17 years. The NIS-CCM utilized the same NIS sampling frame used for the NIS-Child survey.16,17 The respondent to an NIS survey is the parent or guardian, hereinafter referred to as parent, of the child who reports being knowledgeable about the child’s vaccination history. This study includes quantitative survey data from the period July 22, 2021–February 26, 2022. We limited the study to parental report focused on adolescents aged 13–17 years as of the time of interview on the NIS-CCM.
To assess disability, parents were asked the following questions from the American Community Survey – Six Disability Questions (ACS-6)18: “Is [child’s name] deaf or does [he/she] have serious difficulty hearing; Is [name] blind or does [he/she] have serious difficulty seeing, even when wearing glasses; Does [name] have serious difficulty walking or climbing stairs; Because of a physical, mental, or emotional condition, does [name] have serious difficulty concentrating, remembering, or making decisions; Does [name] have difficulty dressing or bathing; and, Because of a physical, mental, or emotional condition, does [name] have difficulty doing errands alone such as visiting a doctor’s office or shopping (not applicable for adolescents aged 13–14 years)?” A ‘yes’ response to any of these questions denotes a disability. A ‘yes’ response to each individual question is indicative of that specific disability type: hearing, vision, mobility, cognition, self-care, and not performing errands independently (not applicable for adolescents aged 13–14 years), respectively. A ‘no’ response to all disability questions is indicative of no disability. All six questions are asked for adolescents ages 15–17 years; whereas all but performing errands independently are asked for adolescents ages 13–14 years, as noted. Disability types are not considered mutually exclusive.
To assess vaccination status, parents were asked19: “Has [child’s name] received at least one dose of a COVID-19 vaccine”; and “How many doses of a COVID-19 vaccine has [child’s name] received?” Among those with unvaccinated children, to classify parent’s intent to have their unvaccinated child vaccinated, they were asked “Would you say you would: definitely get a vaccine for [child’s name]; probably get a vaccine; probably not get a vaccine; definitely not get a vaccine; or are not sure?” Data in this study were limited to those who reported on vaccination status and intent for vaccination as well as disability status (n = 12,445; 90 respondents were excluded due to missing values for one or more of these variables). For this study, fully vaccinated is defined as receipt of the primary series (two or more COVID-19 doses) recommended before April 19, 2023.
To assess potential drivers of COVID-19 vaccine uptake, all parents were asked eleven questions derived from three domains of the Behavioral and Social Drivers of Vaccination (BeSD) framework20,21: thinking and feeling domain (questions assessed concern about the child getting COVID-19 disease, confidence in COVID-19 vaccine safety for the child, and confidence in COVID-19 vaccine’s importance for the child), social processes domain (questions assessed COVID-19 vaccination status of family and friends’ adolescents, receipt of a healthcare provider’s recommendation for the child’s COVID-19 vaccination, and the child’s school’s requirement for COVID-19 vaccination), and practical issues domain (questions assessed overall and by four types of difficulties to get the child vaccinated).1
Research design
We assessed parent-reported vaccination coverage among adolescents by disability status stratified by select sociodemographic characteristics (i.e., age, race and ethnicity, sex, household income, urbanicity, and social vulnerability index2), Additionally, we examined the reported adolescent’s disability type (if applicable), mental health status (ranging from fair or poor to excellent mental health), number of doctor visits in the past 12 months, previous COVID-19 diagnosis (absence or presence), place of vaccination, and respondent’s relationship to the adolescent, stratified by disability status. We calculated unadjusted weighted percentages, along with 95% confidence intervals (CIs), using SAS-callable SUDAAN (version 11.0.3; Research Triangle Institute) and SAS software (version 9.4; SAS Institute) to account for the complex survey design. We performed t-tests to evaluate prevalence differences between groups. Specifically, we first examined the difference in vaccination coverage by overall disability status and each disability type. Then, after stratifying the sample by disability status, we calculated vaccination coverage for each response level of the sociodemographic variables assessed. We compared each response level to a corresponding reference group within each sociodemographic variable. We also compared vaccination coverage among adolescents with disability and without disability by each sociodemographic group. Furthermore, we tested the difference in the prevalence of each BeSD variable among adolescents with or without disability by vaccination status. The NIS-CCM cumulative response rate was 15.1%. The NIS-CCM survey weights adjust for non-response and households without cellular telephones, and these were then calibrated to match counts of adolescents with one or more doses of COVID-19 vaccine by sex within each U.S. Department of Health and Human Services (HHS) region for adolescents aged 13–17 years as of mid-month, using data reported to CDC by jurisdictions. Survey weights and analytic data files were constructed for each approximate month of data collection. All differences noted were statistically significant with p < 0.05. We suppressed estimates that did not meet the National Center for Health Statistics (NCHS) reliability criteria for proportions.3 This activity was reviewed by the Centers for Disease Control and Prevention (CDC) and was conducted consistent with applicable federal law and CDC policy.
Results
The percentage of adolescents reported with any disability who received ≥ 1 dose of COVID-19 vaccine (52.5%) was lower compared to adolescents without disability (58.6%; Table 1). Adolescents with disability were also less likely to be fully vaccinated (48.4%) compared to adolescents without disability (55.3%) (Difference = 6.9%, p-value: 0.0002; data not shown). Additionally, among adolescents who were fully vaccinated, a smaller percentage of adolescents with disability received a booster dose (20.7%) than adolescents without disability (31.6%) (Difference = 10.9%, p-value: 0.0001; data not shown). When COVID-19 vaccination status was examined by disability type, vaccination coverage among adolescents who had disability in cognition (50.8%) or performing errands independently (49.5%) had lower vaccination coverage compared to adolescents without disability (58.6%). There were no statistically significant differences in COVID-19 vaccination coverage for the other disability types (Table 1).
Table 1.
COVID-19 vaccination status of adolescents 13—17 years, by disability status, disability type, and sociodemographic characteristics —National Immunization Survey Child COVID Module July 22, 2021—February 26, 2022.
| N | Weighted % of adolescents with disability |
Adolescents with disability |
Adolescents without disability |
Comparison of proportion≥1 dose vaccinated among those with vs without disability |
|||
|---|---|---|---|---|---|---|---|
| weighted % (95% CI) | ≥ 1 dose Vaccinated weighted % (95% CI) | unadjusted prevalence difference (95% CI) | ≥ 1 dose Vaccinated weighted % (95% CI) | unadjusted prevalence difference (95% CI) | unadjusted prevalence difference (95% CI) | ||
|
| |||||||
| Total | 12,445 | 21.2 (20.0–22.4) | 52.5 (49.2–55.7) | 58.6 (56.9–60.2) | –6.0 (–9.7 to −2.4)f | ||
| Age 13–15 | 7504 | 21.7 (20.1–23.3) | 49.1 (44.9–53.3) | −8.9 (−15.5 to −2.3)g | 56.8 (54.7–58.9) | −4.3 (−7.6 to −1.0)g | −7.7 (−12.4 to −3.0)f |
| 16–17 (Ref) | 4941 | 20.4 (18.6–22.3) | 58.0 (52.9–63.0) | Ref | 61.2 (58.6–63.7) | Ref | −3.1 (−8.8–2.6) |
| Race and ethnicitya | |||||||
| White, non-Hispanic (Ref) | 7087 | 20.1 (18.6–21.7) | 50.4 (46.1–54.7) | Ref | 57.0 (54.9–59.1) | Ref | −6.6 (−11.4 to −1.8)f |
| Black, non-Hispanic | 1352 | 21.1 (18.0–24.7) | 53.8 (44.6–62.8) | 3.5 (−6.7–13.6) | 50.1 (45.5–54.7) | −6.9 ( − 12.0 to −1.8)g | 3.7 (−6.5–14.0) |
| Hispanic | 2318 | 22.8 (20.2–25.6) | 59.2 (52.1–65.9) | 8.8 (0.6–17.0)g | 62.1 (58.2–65.9) | 5.2 (0.8–9.5)g | −3.0 (−10.9–5.0) |
| Other or multiple races, non-Hispanic | 1613 | 22.4 (18.7–26.6) | 48.9 (38.8–59.0) | − 1.5 (−12.6–9.6) | 68.9 (64.0–73.4) | 11.9 (6.8–17.1)g | −20.0 (−31.3 to −8.7)f |
| Sex | |||||||
| Male (Ref) | 6475 | 22.9 (21.3–24.7) | 50.8 (46.6–55.1) | Ref | 56.9 (54.6–59.1) | Ref | −6.0 (−10.9 to − 1.2)f |
| Female | 5918 | 19.3 (17.6–21.0) | 54.7 (49.6–59.6) | 3.8 (−2.8–10.4) | 60.2 (57.8–62.5) | 3.3 (0.0–6.6)g | −5.5 (−11.1–0.0) |
| Disability Typeb | |||||||
| Hearing | 177 | 100 | 48.0 (36.4–59.8) | NA | NA | NA | − 10.6 (−22.7–1.5) |
| Vision | 318 | 100 | 57.8 (48.7–66.3) | NA | NA | NA | −0.8 (−9.8–8.3) |
| Mobility | 148 | 100 | 49.6 (38.0–61.4) | NA | NA | NA | −8.9 (−20.9–3.1) |
| Cognition | 1824 | 100 | 50.8 (47.1–54.4) | NA | NA | NA | −7.8 (−11.8 to −3.8)f |
| Self-care | 179 | 100 | 52.1 (41.3–62.8) | NA | NA | NA | −6.4 (−17.5–4.6) |
| Not performing errands independentlyc | 473 | 100 | 49.5 (42.4–56.6) | NA | NA | NA | − 11.4 (−18.8 to −3.9)f |
| Respondent relationship to child Child's mother or female guardian (Ref) | 8335 | 22.9 (21.5–24.5) | 50.5 (46.8–54.3) | Ref | 57.3 (55.3–59.3) | Ref | −6.8 (−11.1 to −2.6)f |
| Child's father or male guardian | 3464 | 15.0(13.1 − 17.2) | 57.5 (49.8–64.8) | 6.9 (−1.5–15.3) | 63.6 (60.5–66.7) | 6.3 (2.6–10.0)g | −6.2 (−14.3–1.9) |
| Other or unknown | 646 | 26.9 (21.7–32.8) | 58.8 (46.3–70.2) | 8.3 (−4.5–21.0) | 49.1 (42.4–55.8) | −8.2 ( − 15.3 to −1.2)g | 9.7 (−4.2–23.6) |
| Urbanicity | |||||||
| Urban (MSA, principal city) (Ref) | 4010 | 20.8 (18.8–22.9) | 57.9 (52.1–63.5) | Ref | 62.1 (59.2–64.9) | Ref | −4.2 (−10.6–2.3) |
| Suburban (MSA, nonprincipal city) | 5921 | 20.1 (18.5–21.9) | 52.4 (47.6–57.1) | −5.5 (−13.0–1.9) | 61.1 (58.8–63.4) | − 1.0 (−4.6–2.7) | −8.7 (−14.0 to −3.5)f |
| Rural (Non-MSA) | 1971 | 25.3 (22.2–28.8) | 40.2 (33.2–47.5) | −17.8 (−27.0 to −8.6)g | 38.2 (34.6–41.9) | −23.9(−28.6to −19.2)g | 2.0 (−6.1 − 10.0) |
| SVI of county of residenced | |||||||
| Low (Ref) | 4468 | 18.4 (16.6–20.3) | 54.3 (48.6–60.0) | Ref | 60.5 (57.7–63.2) | Ref | −6.2 (−12.5–0.2) |
| Moderate | 4239 | 21.1 (19.2–23.1) | 50.3 (45.0–55.7) | −4.0 (−11.8–3.8) | 59.5 (56.7–62.2) | − 1.0 (−4.9–2.8) | −9.1 (−15.1 to −3.1)f |
| High | 3048 | 23.5 (21.2–25.9) | 52.8 (46.9–58.5) | − 1.6 (−9.8–6.6) | 54.9 (51.9–58.0) | −5.6 (−9.7 to −1.5)g | −2.2 (−8.8–4.4) |
| Household incomee | |||||||
| Below poverty | 1608 | 31.2 (28.0–34.7) | 40.6 (34.9–46.6) | −26.0 (−34.0 to − 17.9)g | 39.2 (35.1–43.5) | −28.3(−33.1to −23.5)g | 1.4 (−5.8–8.6) |
| Above poverty, <$75 k | 2550 | 25.7 (23.2–28.5) | 53.6 (47.4–59.6) | − 13.0 (−21.3 to −4.8)g | 52.7 (49.2–56.1) | −14.8( −19.0to −10.7)g | 0.9 (−6.1–7.9) |
| Above poverty, ≥$75 k (Ref) | 6034 | 14.9 (13.4–16.4) | 66.6 (60.8–71.9) | Ref | 67.5 (65.2–69.7) | Ref | −0.9 (−6.9–5.1) |
| Unknown income | 2253 | 19.3 (16.5–22.6) | 45.6 (37.0–54.5) | −21.0 (−31.4 to −10.5)g | 61.0 (57.0–64.8) | −6.5 ( − 11.1 to −2.0)g | − 15.4 (−25.1 to −5.7)f |
| Adolescenťs mental health Excellent, very good, or good (Ref) | 11,228 | 17.1 (15.9–18.3) | 52.9 (49.1–56.7) | Ref | 58.4(56.7–60.1) | Ref | −5.5 (−9.7 to − 1.3)f |
| Fair or poor | 1171 | 56.4 (51.9–60.8) | 51.5 (45.2–57.7) | −1.5 (−8.8–5.9) | 61.3 (54.3–67.8) | 2.9 (−4.1–9.8) | −9.8 (−19.0 to −0.6)f |
| Number of times child has seen doctor or other health professional in past 12 months | |||||||
| 0 (Ref) | 1728 | 17.9(15.1–21.1) | 47.8 (38.8–57.0) | Ref | 48.7 (44.4–52.9) | Ref | −0.9 (−11.0–9.3) |
| 1 | 3872 | 15.4(13.6–17.3) | 51.3 (44.6–58.0) | 3.5 (−7.9–14.9) | 60.4(57.5–63.1) | 11.7 (6.6–16.8)g | −9.0 (−16.3 to −1.7)f |
| 2–3 | 4509 | 20.4 (18.5–22.5) | 52.9 (47.4–58.5) | 5.1 (−5.6–15.9) | 59.3 (56.6–61.9) | 10.6 (5.6–15.6)g | −6.3 (−12.5 to −0.1)f |
| 4+ | 2239 | 34.4 (31.3–37.8) | 54.2 (48.0–60.2) | 6.4 (−4.7–17.4) | 63.4 (59.2–67.5) | 14.8 (8.8–20.7)g | −9.3 (−16.6 to −1.9)f |
| Child ever had COVID-19 | |||||||
| Yes (Ref) | 2498 | 21.6 (19.2–24.3) | 41.2 (35.1–47.7) | Ref | 45.2 (41.9–48.4) | Ref | −3.9 (−11.1–3.2) |
| No | 9866 | 20.9 (19.6–22.3) | 56.3 (52.6–60.1) | 15.1 (7.8–22.5)g | 63.3 (61.5–65.2) | 18.2 (14.4–21.9)g | −7.0 (−11.2 to −2.8)f |
| COVID-19 vaccination status | |||||||
| Fully vaccinated and received at least 1 booster dose | 858 | 12.0 (9.4–15.2) | 100 | NA | 100 | NA | NA |
| Fully vaccinated | 9135 | 19.0(17.7–20.5) | 100 | NA | 100 | NA | NA |
| Received only 1 dose | 526 | 24.7 (18.8–31.8) | 100 | NA | 100 | NA | NA |
Abbreviations: CI = confidence interval; MSA = metropolitan statistical area; NA = not applicable; Ref = referent group; SVI = social vulnerability index.
NA is used to describe the absence of subgroups for adolescents without disability when compared to adolescents with specific disability types. All disability type comparisons are made to the general adolescents without disability category.
Race of child was reported by parent or guardian respondent. Adolescents of Hispanic ethnicity may be of any race. Adolescents identified as multiple races had more than one race category selected.
For statistical significance test, the vaccination coverage among adolescents with each disability type was compared to the coverage among adolescents without disability.
Not performing errands independently disability question was only asked to parents/guardians with adolescents 15–17 years. T-test was performed among adolescents 15–17 years who had non-missing value for vaccination status.
CDC/Agency for Toxic Substances and Disease Registry Social Vulnerability Index (SVI) uses 15 U S. census variables to help officials identify communities that may need support before, during, or after disasters.
Income/Poverty level was defined based on total family income in the past calendar year, and the U.S. Census poverty thresholds for that year specified for the applicable family size and number of adolescents <18 years. Poverty thresholds are available at .
Statistically significant at P < 0.05 comparing COVID-19 vaccination coverage among adolescents with disability to coverage among adolescents without disability.
Statistically significant at P < 0.05 comparing COVID-19 vaccination coverage between each response level and the referent group.
When comparing reported COVID-19 vaccination coverage among adolescents by disability status and sociodemographic variables, vaccination coverage was lower among adolescents with disability compared to adolescents without disability among several sociodemographic characteristics, including among younger adolescents (aged 13–15 years), adolescents who are non-Hispanic White or non-Hispanic other4 or multiple races, males, adolescents where the respondent was a female parent or guardian, adolescents living in a suburban metropolitan statistical area (MSA), and adolescents living in areas of moderate social vulnerability (Table 1). Vaccination coverage was also lower among adolescents with disability compared to adolescents without disability for adolescents who have never had COVID-19, and among all strata of adolescents’ mental health status (excellent, very good, or good; fair or poor mental health) and having seen a doctor or health professional at a doctor’s office, a clinic, or some other place (excluding being hospitalized overnight, emergency department visits, home visits, dental visits, or telephone calls) 1, 2–3, or ≥4 times in the past 12 months.
For both adolescents with and without disability reported vaccination coverage was higher among Hispanic adolescents and among those who had never had COVID-19 compared with non-Hispanic White adolescents and adolescents who had ever had COVID-19, respectively (Table 1). Vaccination coverage was lower among adolescents aged 13–15 years, those living in a rural non-MSA, and those living in lower-income households (below the poverty level and above the poverty level but with an annual household income <$75 K) compared with adolescents aged 16–17 years, those living in an urban MSA, and those living in higher-income (≥$75 K) households, respectively.
Only among adolescents without disability, vaccination coverage differed by additional demographic and health-related characteristics (Table 1). Among adolescents without disability, vaccination coverage was lower for non-Hispanic Black adolescents, and adolescents living in areas of higher social vulnerability, compared with non-Hispanic White adolescents, when the respondent was a female parent, and adolescents living in areas of lower social vulnerability, respectively. When the respondent was a male parent, vaccination coverage was higher for adolescents with non-Hispanic other/multiple races, females, and among adolescents who had seen a doctor or health professional in the past 12 months. Whereas, when the respondent was a female parent, vaccination coverage was higher for non-Hispanic White adolescents, males, and adolescents who had not seen a doctor or health professional in the past 12 months.
There were no differences observed between adolescents with and without disability as related to place of vaccination (Table 2). All adolescents were more likely to be vaccinated in pharmacies or drug stores (46.6% and 45.6% for adolescents with disability and without disability, respectively) and least likely to be vaccinated in other nonmedically related places (4.3% and 4.5% for adolescents with disability and without disability, respectively) (Table 2).
Table 2.
Place of receiving COVID-19 vaccination among children 13–17 years, by disability status — National Immunization Survey Child COVID Module, July 22, 2021—February 26, 2022.
| With disability |
Without disability |
With disability vs. without disability |
||||
|---|---|---|---|---|---|---|
| N | weighted % (95% CI) | n | weighted % (95% CI) | unadjusted prevalence difference (95% CI) | p value | |
|
| ||||||
| Place of most recent COVID-19 vaccination | ||||||
| Pharmacy or drug store | 725 | 46.6 (42.6–50.6) | 3314 | 45.6 (43.8–47.4) | 1.0 (−3.4–5.4) | 0.6558 |
| Medical place | 646 | 35.9 (32.3–39.8) | 2896 | 34.9 (33.2–36.6) | 1.1 (−3.0–5.2) | 0.6055 |
| Mass vaccination site | 151 | 8.3 (6.5–10.5) | 899 | 10.0(9.0–11.2) | −1.8 (−4.0–0.5) | 0.1315 |
| Elementary or middle or high school | 86 | 4.9 (3.5–6.8) | 471 | 5.0 (4.4–5.8) | −0.1 (−1.9–1.6) | 0.8821 |
| Other nonmedically related place | 67 | 4.3 (2.8–6.4) | 357 | 4.5 (3.8–5.2) | −0.2 (−2.1–1.7) | 0.8364 |
Parental report of COVID-19 vaccination status and intent to vaccinate their adolescent varied by children’s disability status. Parents of adolescents with disability were more likely to indicate they definitely would get their child vaccinated compared to parents of those without disability (9.9% vs 6.5%); they were also more likely to report that they definitely would not get their child vaccinated compared to parents of adolescents without disability (14.9% vs 11.8%) (Fig. 1).
Fig. 1.

Parental report of COVID-19 vaccination status and intent to vaccinate their adolescents by disability status among adolescents 13–17 years —National Immunization Survey Child COVID Module, July 22, 2021–February 26, 2022. * Statistically significant at P < 0.05 comparing proportions of each level of COVID-19 vaccination status and parental intent among adolescents with disability with proportions among adolescents without disability. Categories are mutually exclusive, however percentages among those with and without disability may not add up to 100% due to rounding.
Parents’ reported attitudes and experiences related to COVID-19 vaccination varied depending on their adolescent’s disability status and vaccination status. Parents of adolescents with disability were more likely than those without disability to report being very or moderately concerned about their child getting COVID-19 disease regardless of vaccination status (vaccinated: 54.1% vs. 48.8%, respectively; unvaccinated: 49.4% vs. 37.9%, respectively) (Fig. 2). Among parents of adolescents who were vaccinated, those who had adolescents with disability were less likely to report they had complete or very high confidence in vaccine safety for their adolescent (77.3% vs. 81.5% and that almost all or many friends and family had their adolescents vaccinated (57.0% vs. 67.6%), compared with parents of adolescents without disability. Parents of vaccinated adolescents with and without disability were equally likely to report that the vaccination is important, was recommended by a healthcare provider, was a school requirement for the adolescent, and that they had difficulty getting their adolescent vaccinated. Parents of unvaccinated adolescents with disability were more likely to report it was very or somewhat difficult to get their child vaccinated (19.1% vs. 12.9%), that vaccination sites for their child were not open at convenient times (7.6% vs. 3.9%), they had difficulty with not knowing where to get their child vaccinated (7.2% vs. 2.7%), and difficulty getting to vaccination sites for their child (6.0% vs. 3.0%), compared with parents of unvaccinated adolescents without disability.
Fig. 2.

Parental report of COVID-19 vaccine key attitudes and experiences for their adolescents 13–17 years, by disability status and vaccination status for their adolescents — National Immunization Survey Child COVID Module, July 22, 2021–February 26, 2022. The error bars in the figure are 95% confidence intervals for corresponding percentages. * Statistically significant at P < 0.05 comparing prevalence of each BeSD of COVID-19 vaccination among adolescents with disability with prevalence among adolescents without disability.
Discussion
COVID-19 vaccinations have been safe and effective in reducing the risk of infection and in preventing serious illness and death due to SARS-CoV-2.22,23 Additionally, there is some evidence that vaccination reduces the occurrence and severity of post-acute sequelae of SARS-CoV-2 (PASC)24 also known as “long COVID”, which has been associated with post-infection disability.25,26 Regardless of disability status, adolescents tend to be at lower risk for serious illness and death due to COVID-19 particularly compared to the highest-risk older adults.13 However, individuals with disability are at higher risk for serious illness and death due to COVID-19 at any age.5,7 Given the increased risk for a negative impact due to COVID-19 and the proven effectiveness of vaccination, high vaccination coverage for adolescents with disability is an important preventive measure. However, we found that vaccination coverage was lower for adolescents with disability (52.5%) compared to adolescents without disability (58.6). Even among those who were fully vaccinated, fewer adolescents with disability had received a booster dose (20.7%) than those without disability (31.6%). Further examination of vaccination coverage by disability status indicated differences by factors such as sociodemographic characteristics, adolescent mental health status, and number of reported adolescent doctor visits within the past year.
Reported COVID-19 vaccination coverage was lower for adolescents in this survey than that for routine adolescent vaccinations, which tend to have high coverage apart from the Human papillomavirus (HPV) vaccination.27 COVID-19 vaccination coverage was low regardless of disability status, and vaccination coverage was higher among Hispanic adolescents compared to Non-Hispanic White adolescents. This finding is consistent with higher vaccination among Hispanic adolescents for the meningococcal vaccine and higher intent to vaccinate for COVID-19 among Hispanic parents.27–30 Also, for all adolescents, those who never had COVID-19 were more likely to be vaccinated, possibly reflecting the protective effect of the vaccination and an association between likelihood to be vaccinated and increased health-promoting behaviors reducing exposure.31 Another contributing factor might be parents of adolescents who had COVID-19 are less likely to have their child vaccinated because they are less concerned about their child getting COVID-19 again. Recent data indicate that younger children have lower COVID-19 vaccination coverage than older children (e.g., 36.5% of children aged 5–11 years as compared to 69.9% of children aged 12–17 years received 1 dose).32 In this study, younger adolescents (aged 13–15 years), both with and without disability, were less likely to be vaccinated, potentially reflecting increased hesitancy among parents of younger adolescents or a shorter time for which adolescents less than 16 years were recommended for COVID-19 vaccine. Similar to reported patterns in adults, adolescents living in rural areas and from lower to mid-level income families were less likely to be vaccinated.33
Despite some similar patterns of vaccination coverage among adolescents with and without disability across several different sociodemographic and health-related factors, vaccination coverage among adolescents with disability was reported to be consistently lower compared to adolescents without disability. In this study, the gap in receipt of COVID-19 vaccination between the adolescents with and without disability was greatest among those who were younger, male, non-Hispanic White, or non-Hispanic other/multiple races. In addition to usual health disparity patterns indicating less vaccination coverage in rural areas and areas with high Social Vulnerability Index (SVI),33,34 which was observed among all adolescents with respect to a rural domicile and among adolescents with disability with respect to SVI, those with disability living in suburban and moderate SVI areas were significantly less likely to be vaccinated than their peers without disability. Vaccination was also lower for the disability group across both parental rating levels of adolescent mental health (poor to very good). While seeing a healthcare provider once or more annually was associated with higher vaccination rates among adolescents without disability, there was not an association between the number of health care provider visits in the past 12 months with vaccination coverage among persons with disability. Further evaluation of the differential association between seeing a healthcare provider and vaccination status among adolescents with and without disability is warranted. Other studies indicate that factors influencing COVID-19 vaccination are different and more complex than those with other routine vaccinations.29 A recent study of parents of adolescents in the US found that parental vaccination status, use of prevention measures, COVID-19 misconceptions, and vaccine mistrust predicted COVID-19 vaccination coverage among the adolescents.35 Our findings indicate potential additional complexity among influences on vaccination status among some subgroups of adolescents with disabilities compared to those without.
Among adolescents who were vaccinated, parents reported similar attitudes and experiences regardless of the disability status of their adolescents. One exception was that parents of adolescents with disability were more likely to report being very or moderately concerned about their adolescent getting COVID-19 regardless of vaccination status. Further evaluation of the reasons for lower vaccination coverage despite higher concern among parents of adolescents with disability is warranted. Regardless of disability status, parents of vaccinated adolescents almost universally (97%) indicated that vaccination is important, about 50% indicated that their healthcare provider recommended COVID-19 vaccination, only 11–12% indicated that vaccination was a school requirement for their adolescent, and only 7–8% reported experiencing difficulty in getting their adolescent vaccinated. Although the majority from both groups reported complete or high confidence in COVID-19 vaccine safety and that almost all or many of their friends and family had their children vaccinated, confidence and coverage among friends and family were lower for adolescents with disability.
Among unvaccinated adolescents, over half of their parents indicated that vaccination is important; however, confidence in vaccine safety, vaccination coverage among friends and family, a healthcare provider’s recommendation, and awareness of a school requirement were low for both adolescents with and without disability. Given the effectiveness of COVID-19 vaccines and the less-than-ideal vaccination rate among all adolescents in this study, more universal strategies to increase confidence and receipt of vaccinations and boosters are warranted.36 Despite similar attitudes, parents of adolescents with disability were more likely to indicate they would definitely get their child vaccinated than parents of adolescents without disability. Barriers to vaccine access might contribute to lower vaccination rates among adolescents with disability despite parental endorsement of the importance of vaccination and being more likely to report intent to vaccinate. Parents of adolescents with disability were also more likely to indicate that they would not get their child vaccinated which might also contribute to lower vaccination rates. Parents of unvaccinated adolescents with disability reported experiencing more difficulty than parents without disability with getting their child vaccinated, not knowing where to go for a vaccine, difficulty getting to a vaccination site, and with neighborhood vaccination sites being open at convenient times. These findings parallel previous findings from the NIS in adults with disability.13 Strategies to increase availability and accessibility of vaccination locations, times, information, and strategies to better include people with a range of functional disabilities (e.g., vision, hearing, understanding, communication, mobility) have been recommended (13) and implemented37 with tools available to assist.38
Although disability severity and associated support needs were not measured in this survey, the only statistically significant differences in vaccination of adolescents with disability compared to those without was observed among adolescents whose parents reported their child had cognitive disabilities or they were unable to perform errands independently. The significance of this finding is not readily apparent but could indicate that adolescents with challenges understanding or following directions and/or needing more support to participate in being vaccinated might have specific issues with vaccination access and participation. This finding may be further explored in other studies with a focus on identifying, implementing, and evaluating ways to assess functional needs and improve access to vaccination for families of adolescents with disability.37,39,40
While it might be expected that healthcare provider or school locations would be where COVID-19 vaccination was most likely to occur for children and adolescents, the most common location was the pharmacy or drugstore for both groups of adolescents (approximately 46%), possibly mirroring where their parents were vaccinated due to the ease of access and routine vaccination distribution locations. Given the amount of time spent in school settings and the presence of educators and other specialists who might be able to assist with supporting a student with additional needs, further consideration for reaching students with disability in school settings is warranted.41
This study might be subject to at least four limitations. First, the response rates were low (15%) and bias in estimates might remain after weighting. Survey weights were calibrated to the specific COVID-19 vaccine administration data by region, age group, and sex to mitigate possible bias from incomplete sample frame and nonresponse. Second, vaccination status was parent-reported and subject to misclassification and social desirability bias. The weighting calibration to the COVID-19 vaccination data might also mitigate misclassification bias at the group level, although it cannot correct for individual respondent-level misclassification. Third, disability status was based on parent report of serious difficulty in one of six functional areas with no additional information on the level of disability or support needs. Finally, the survey is cross-sectional and thus cause and effect relationships cannot be determined.
Conclusion
The findings from this study suggest that adolescents with disability were less likely compared to adolescents without disability to have received at least one dose of COVID-19 vaccine, to be fully vaccinated, or to have received a booster dose among those fully vaccinated. There was lower vaccination coverage among adolescents with cognitive disability or disability in performing errands independently compared to adolescents without disability. Parents of unvaccinated adolescents with disability reported higher intent to get their adolescents vaccinated, but also experiencing greater difficulty in doing so. With less than half of adolescents with disability being fully vaccinated and only one-fifth among them boosted, there are significant gaps in the use of one of the most effective and safe prevention tools available to reduce the risk of serious illness or death from COVID-19. These findings highlight the need for focused outreach to this population, including increased accessibility and education among families and providers regarding the importance of COVID-19 vaccination among youth with disability and their families.13,42,43 This situation has increased importance with the recommendation for the updated bivalent COVID-19 vaccine; as of April 19, 2023, persons 6 years and older are up-to-date if they have received at least one bivalent COVID-19 vaccine.44 This work highlights the importance of collecting disability status and type in all public health data collection systems to address systemic inequities for this population.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Disclaimer
The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Footnotes
Conflicts of interest
The authors have no conflicts of interest to report for this study.
Financial disclosure
The authors have no financial interests to report for this study.
Prior publication
The manuscript, or any part of it, has not been published and will not be submitted elsewhere for publication while being considered by the Disability and Health Journal.
NIS Child COVID Module (NIS-CCM) Hard Copy Questionnaire Q2/2022 (cdc.gov).
NCHS Vital and Health Statistics, Series 2, Number 175, August 2017 (cdc.gov)
Non-Hispanic other races include: Non-Hispanic American Indian, Non-Hispanic Alaska Native, Non-Hispanic Asian, Non-Hispanic Native Hawaiian and Non-Hispanic Pacific Islander.
References
- 1.Zablotsky B, Black LI, Maenner MJ, et al. Prevalence and trends of developmental disabilities among children in the United States: 2009–2017. Pediatrics. 2019;144(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Okoro CA, Hollis ND, Cyrus AC, Griffin-Blake S. Prevalence of disabilities and health care access by disability status and type among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(32):882–887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Carroll DD, Courtney-Long EA, Stevens AC, et al. Vital signs: disability and physical activity–United States, 2009–2012. MMWR Morb Mortal Wkly Rep. 2014;63(18):407–413. [PMC free article] [PubMed] [Google Scholar]
- 4.Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) Guidance for People with Underlying Health Conditions. Atlanta, GA: US Department of Health and Human Services: CDC; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. [Google Scholar]
- 5.So CN, Ryerson AB, Yeargin-Allsopp M, et al. Brief Summary of Findings on the Association between Disabilities and Severe COVID-19 Outcomes. CDC COVID-19 Scientific Brief [Internet]; 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/downloads/clinical-care/C-Disability-Review.pdf. [Google Scholar]
- 6.Landes SD, Turk MA, Formica MK, McDonald KE, Stevens JD. COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State. Disabil Health J. 2020;13(4):100969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Turk MA, Landes SD, Formica MK, Goss KD. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis. Disabil Health J. 2020;13(3):100942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sherby MR, Kalb LG, Coller RJ, et al. Supporting COVID-19 school safety for children with disabilities and medical complexity. Pediatrics. 2022;149(12 suppl 2). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Allison KM, Levac DE. Impact of the COVID-19 pandemic on therapy service delivery and functioning for school-aged children with disabilities in the United States. Disabil Health J. 2022;15(2):101266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Colvin MKM, Reesman J, Glen T. The impact of COVID-19 related educational disruption on children and adolescents: an interim data summary and commentary on ten considerations for neuropsychological practice. Clin Neuropsychol. 2022;36(1):45–71. [DOI] [PubMed] [Google Scholar]
- 11.O’Neill J, Newall F, Antolovich G, Lima S, Danchin M. Vaccination in people with disability: a review. Hum Vaccines Immunother. 2020;16(1):7–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Boyle CA, Fox MH, Havercamp SM, Zubler J. The public health response to the COVID-19 pandemic for people with disabilities. Disabil Health J. 2020;13(3): 100943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Ryerson AB, Rice CE, Hung MC, et al. Disparities in COVID-19 vaccination status, intent, and perceived access for noninstitutionalized adults, by disability status - national immunization survey adult COVID Module, United States, may 30-june 26, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(39):1365–1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Centers for Disease Control and Prevention. COVID-19 Vaccines for Children and Teens. Atlanta, GA: US Department of Health and Human Services: CDC; 2021. [updated August 24, 2022]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/children-teens.html. [Google Scholar]
- 15.Centers for Disease Control and Prevention. Guidance for Vaccinating Older Adults and People with Disabilities: Ensuring Equitable COVID-19 Vaccine Access. Atlanta, GA: US Department of Health and Human Services: CDC; 2020. [updated January 20, 2022]. Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/older-adults-and-disability/access.html. [Google Scholar]
- 16.Wolter KK, Smith PJ, Khare M, et al. Statistical methodology of the national immunization survey, 2005–2014. Vital Health Stat. 2017;1(61):1–107. [PubMed] [Google Scholar]
- 17.Centers for Disease Control and Prevention. About the National Immunization Surveys (NIS). Atlanta, GA: US Department of Health and Human Services: CDC; 2019. Available from: https://www.cdc.gov/vaccines/imz-managers/nis/about.html. [Google Scholar]
- 18.Office of the Assistant Secretary for Planning and Evaluation. HHS Implementation Guidance on Data Collection Standards for Race, Ethnicity, Sex, Primary Language, and Disability Status. Washington, DC: US Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation; 2011. Available from: https://aspe.hhs.gov/basic-report/hhs-implementation-guidance-data-collection-standards-race-ethnicity-sex-primary-language-and-disability-status#Data. [Google Scholar]
- 19.Centers for Disease Control and Prevention. National Immunization Surveys (NIS). Atlanta, GA: US Department of Health and Human Services: CDC; 2022. Available from: https://www.cdc.gov/vaccines/imz-managers/nis/downloads/nis-teen-questionnaire-q2-2022.pdf. [Google Scholar]
- 20.World Health Organization. Development of Tools to Measure Behavioural and Social Drivers (BeSD) of Vaccination: Progress Report 2020.
- 21.Brewer NT. What works to increase vaccination uptake. Acad Pediatr. 2021;21(4S):S9–S16. [DOI] [PubMed] [Google Scholar]
- 22.Thompson MG, Natarajan K, Irving SA, et al. Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance - VISION network, 10 States, August 2021-january 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4): 139–145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Patel R, Kaki M, Potluri VS, Kahar P, Khanna D. A comprehensive review of SARS-CoV-2 vaccines: pfizer, moderna & johnson & johnson. Hum Vaccines Immunother. 2022;18(1):2002083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kuodi P, Gorelik Y, Zayyad H, et al. Association between Vaccination Status and Reported Incidence of Post-acute COVID-19 Symptoms in Israel: A Cross-Sectional Study of Patients Tested between March 2020 and. November 2021. medRxiv. 2022:2022.01.05.22268800. [Google Scholar]
- 25.Sivan M, Rayner C, Delaney B. Fresh evidence of the scale and scope of long covid. BMJ. 2021;373:n853. [DOI] [PubMed] [Google Scholar]
- 26.UdoHaHSaUDo Justice. Long COVID” as a Disability under the ADA, Section 504, and Section 1557 2021 [updated; July 26, 2021. Available from: https://www.hhs.gov/civil-rights/for-providers/civil-rights-covid-19/guidance-long-coviddisability/index.html#footnote1_okh8n1z.
- 27.Pingali C, Yankey D, Elam-Evans LD, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 Years - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(35):1183–1190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Niccolai LM, Yakely AE, Hansen CE. Up-to-date coverage with meningococcal vaccine among adolescents age 17years: patterns and correlates in the United States, 2017. Vaccine. 2019;37(40):5934–5938. [DOI] [PubMed] [Google Scholar]
- 29.Middleman AB, Klein J, Quinn J. Vaccine hesitancy in the time of COVID-19: attitudes and intentions of teens and parents regarding the COVID-19 vaccine. Vaccines (Basel). 2021;10(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Fisher CB, Gray A, Sheck I. COVID-19 pediatric vaccine hesitancy among racially diverse parents in the United States. Vaccines (Basel). 2021;10(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zhang KC, Fang Y, Cao H, et al. Parental acceptability of COVID-19 vaccination for children under the age of 18 Years: cross-sectional online survey. JMIR Pediatr Parent. 2020;3(2):e24827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Centers for Disease Control and Prevention. CDC COVID Data Tracker: Vaccination Demographics Trends. Atlanta, GA: US Department of Health and Human Services: CDC; 2022. Available from: https://covid.cdc.gov/covid-data-tracker/#vaccination-demographics-trends. [Google Scholar]
- 33.Saelee R, Zell E, Murthy BP, et al. Disparities in COVID-19 vaccination coverage between urban and rural counties - United States, december 14, 2020-january 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(9):335–340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Thakore N, Khazanchi R, Orav EJ, Ganguli I. Association of Social Vulnerability, COVID-19 vaccine site density, and vaccination rates in the United States. Healthc (Amst). 2021;9(4):100583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Gray A, Fisher CB. Determinants of COVID-19 vaccine uptake in adolescents 12–17 Years old: examining pediatric vaccine hesitancy among racially diverse parents in the United States. Front Public Health. 2022;10:844310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Centers for Disease Control and Prevention. 12 COVID-19 Vaccination Strategies for Your Community. Atlanta, GA: US Department of Health and Human Services: CDC; 2023. Available from: https://www.cdc.gov/vaccines/covid-19/vaccinate-with-confidence/community.html. [Google Scholar]
- 37.Sebring JCH, Capurro G, Kelly C, Jardine CG, Tustin J, Driedger SM. “None of it was especially easy”: improving COVID-19 vaccine equity for people with disabilities. Can J Public Health. 2022;113(6):887–897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Centers for Disease Control and Prevention. COVID-19 Vaccination for Children and Teens with Disabilities. Atlanta, GA: US Department of Health and Human Services: CDC; 2023. Available from: https://www.cdc.gov/ncbddd/humandevelopment/covid-19-vaccination-for-youth.html. [Google Scholar]
- 39.Tinker SC, Cogswell ME, Peacock G, Ryerson AB. Important considerations for COVID-19 vaccination of children with developmental disabilities. Pediatrics. 2021;148(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Centers for Disease Control and Prevention. COVID-19: Toolkit for People with Disabilities. Atlanta, GA: US Department of Health and Human Services: CDC; 2022. Available from: https://www.cdc.gov/ncbddd/humandevelopment/covid-19/toolkit-for-people-with-disabilities.html. [Google Scholar]
- 41.Hofstetter AM, Schaffer S. Childhood and adolescent vaccination in alternative settings. Acad Pediatr. 2021;21(4S):S50–S56. [DOI] [PubMed] [Google Scholar]
- 42.Abdullahi LH, Kagina BM, Ndze VN, Hussey GD, Wiysonge CS. Improving vaccination uptake among adolescents. Cochrane Database Syst Rev. 2020;1: CD011895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Rotenberg S, Downer MB, Cooper J. Making COVID-19 vaccinations accessible for people with disabilities. Vaccine. 2021;39(40):5727–5728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Centers for Disease Control and Prevention. Interim Clinical Considerations for Use of COVID-19 Vaccines. Atlanta, GA: US Department of Health and Human Services: CDC; 2023. Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html. [Google Scholar]
